PhysicianDana Farber Cancer InstituteBoston, Massachusetts, United States
OA-55: Real world experience of patients treated with teclistamab: a BCMA-directed bispecific t-cell engaging therapy for multiple myeloma
Friday, September 29, 20234:42 PM – 4:54 PM EEST